Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: CanSino Biologics

China’s Ad5-nCoV COVID-19 Vaccine Granted Conditional Marketing Authorization

This week, the China National Medical Products Administration (NMPA) granted conditional marketing authorization of Recombinant COVID-19 Vaccine (Adenovirus Type 5 […]

China’s Ad5-nCoV COVID-19 Vaccine Granted Conditional Marketing Authorization
1 week ago
Share

Pakistan Procures 10.6m Doses of Ad5-nCoV for $14 Per Dose but Seeks to Diversify with Other Vaccine Makers

CanSino Biologics, one of China’s leading vaccine makers, inked a deal with Pakistan’s government to sell the Ad5-nCoV vaccine candidate […]

Pakistan Procures 10.6m Doses of Ad5-nCoV for $14 Per Dose but Seeks to Diversify with Other Vaccine Makers
3 months ago
Share

Mexico Secures COVID-19 Vaccine Candidates from CanSino Biologics & Others Via COVAX

Mexico was active recently in the investigational vaccine market, securing two deals with two different companies for a total of […]

Mexico Secures COVID-19 Vaccine Candidates from CanSino Biologics & Others Via COVAX
4 months ago
Share

Pakistan Struggles to Recruit Volunteers for Phase 3 CanSino Biologics Vaccine Trial: Military Involved

Pakistan, the fifth most populous nation in the world, recently geared up to support a Phase 3 COVID-19 vaccine clinical […]

Pakistan Struggles to Recruit Volunteers for Phase 3 CanSino Biologics Vaccine Trial Military Involved.
4 months ago
Share

Will China Supply Much of the World’s Vaccine for COVID-19? WHO In Discussions to do Just That

The World Health Organization (WHO) now purportedly considers China as its strategic COVID-19 vaccine supplier as the world’s most populous […]

Will China Supply Much of the World’s Vaccine for COVID-19 WHO In Discussions to do Just That
5 months ago
Share

CanSino Biologics Inks Deal with Malaysian Holding Company to Prepare Commercialization & Distribution of Ad5-nCoV COVID-19 Vaccine

Indonesia is preparing to support the commercialization of CanSino Biologics’ Ad5-nCoV vaccine candidate as Solution Biologics Sdn Bhd (SOLBIO), a […]

CanSino Biologics Inks Deal with Malaysian Holding Company to Prepare Commercialization & Distribution of Ad5-nCoV COVID-19 Vaccine
5 months ago
Share

CanSino Biologics’ Ad5-nCOV Tested in Phase 3 Clinical Trials in Russia

According to local reports out of Russia (Moscow Times), the Phase 3 clinical trial investigating Cansino Biologics’ COVID-19 vaccine candidate, […]

CanSino Biologics’ Ad5-nCOV Tested in Phase 3 Clinical Trials in Russia
5 months ago
Share

China’s Government Regulators Rushing Vaccine Candidates to Emergency Use? Other Countries Following?

As seven vaccines worldwide have moved to the final stages of testing (e.g. Phase 3 clinical trials), four of them […]

China’s Government Regulators Rushing Vaccine Candidates to Emergency Use Other Countries Following
6 months ago
Share

China & Canada Political Tension Likely the Culprit: COVID-19 Vaccine Trial Terminated

Canada has finally made the call to terminate the CanSino Biologics Ad5-nCoV clinical trial, the nation’s first such study targeting […]

China & Canada Political Tension Likely the Culprit COVID-19 Vaccine Trial Terminated
6 months ago
Share

Canada Continues to Wait for its Negotiated COVID-19 Vaccine Candidate: Still ‘Stuck’ in Chinese Customs

Although TrialSite has already reported that the Canadian government has gone to a “Plan B” for COVID-19 vaccines, the issue […]

Canada Continues to Wait for its Negotiated COVID-19 Vaccine Candidate Still ‘Stuck’ in Chinese Customs
6 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.